Table 4 Multivariate analysis of disease-free survival

From: Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy

 

Adjusted HR (95% CI)

P -value

Histology

MAC

7.96 (3.76–16.8)

<0.001

Non-MACa

1

 

T stage

T4

1.94 (1.13–3.34)

0.017

T1–3

1

 

N stage

N2

2.39 (1.48–3.85)

<0.001

N0–1

1

 

Angiolymphatic invasion

Present

2.83 (1.64–4.87)

<0.001

Absent

1

 

Perineural invasion

Present

2.27 (1.36–3.79)

0.002

Absent

1

 
  1. Abbreviations: CI=confidence interval; HR=hazard ratio; MAC=mucinous adenocarcinoma.
  2. aNon-MAC includes non-mucinous adenocarcinoma and adenocarcinoma with intermediate mucinous component.